Skip to Main Content

Paper Details

Non-neutralizing SARS-CoV-2 N-terminal domain antibodies protect mice against severe disease using Fc-mediated effector functions.
bioRxiv
3
2023
DH1052, Fc, N, NTD, NTD neutralizing antibody, SARS, SARS-CoV, SARS-CoV-2, SARS-CoV-2 N-terminal domain antibodies, SARS-CoV-2 Spike N-terminal domain, coronavirus, cynomolgus macaques, human, mice, pathogen
Author NameAffiliation
Barton F HaynesDuke Human Vaccine Institute, Duke University School of Medicine
Barton F HaynesDuke University
Barton F HaynesDuke University School of Medicine
Ralph S BaricUniversity of North Carolina at Chapel Hill
Ralph S BaricUniversity of North Carolina at Chapel Hill
  • 1 - 5

Datasets

Release 1.2